Cargando…
OA06.07 Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
Autores principales: | Kidane, B., Spicer, J., Kim, J.O., Gerard, I.J., Abdulkarim, B., Fiset, P.-O., Cecchini, M.J., Malthaner, R.A., Inculet, R.I., Wakeam, E., Fortin, D., Wawryko, P., Qing, G., Palma, D.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452026/ http://dx.doi.org/10.1016/j.jtho.2022.07.039 |
Ejemplares similares
-
SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
por: Kidane, Biniam, et al.
Publicado: (2020) -
OA06.05 Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
por: Wolfhagen, N., et al.
Publicado: (2022) -
OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
por: Mack, P.C., et al.
Publicado: (2022) -
OA06.06 Impact of Systemic Anti-cancer Treatments on Outcomes of COVID-19 in Patients with Thoracic Cancers: CCC19 Registry Analysis
por: Kulkarni, A., et al.
Publicado: (2022) -
OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
por: Hernandez, A., et al.
Publicado: (2022)